The objectives of the current study are (i) to maximize the ocular bioavailability of dorzolamide hydrochloride (DZD) through; (a) enhancement of the DZD corneal transport using various concentrations of selected natural terpene-4-ol enhancers, (b) increasing the contact time of the drug with the absorbing tissues of the eye using selected carbopol-934 (C-934) as mucoadhesive to reduce the extensive pre-corneal loss of the installed dose due to the physiologically normal fast tear-washout, and (ii) to assess the in vivo intraocular pressure (IOP) lowering effects of the gel test formulations using normotensive New Zealand albino rabbits. In this study, DZD was formulated as 2% formulations ophthalmic gels containing different concentrations of C-934 as mucoadhesive, as well as, with various concentrations of terpene-4-ol as a natural corneal penetration enhancers. The transport of DZD from the gel formulations was quantitatively determined using in vitro diffusion experiments. The permeability parameters of DZD were calculated employing the most appropriate mathematical equations. Further, the in vivo IOP lowering effects of the test formulations were also assessed using the TONO-PEN®XL applanation tonometer in normotensive New Zealand albino rabbits. The overall results revealed that there is a direct correlation between both the in vitro permeability parameters and the contact period with the ocular tissues and the in vivo ΔIOP. In such case, the in vitro permeability parameters of DZD could be used as a determinant for the in vivo IOP measurements. The magnitude of the DZD-IOP lowering effects as well as the durations of actions for the test formulations has been found to be greatly dependent upon (a) the concentration of the terpene-4-ol corneal penetration enhancer and (b) the duration of contact period with the ocular tissues, which was found to be a single-valued function of the C-943 mucoadhesive concentration.

The purpose of this study was to develop a cell-based screening assay for identification of small molecules for the treatment of asthma. Eosinophils are leukocytes that contribute to the pathology of asthma. Lidocaine inhibits interleukin-5 (IL-5)-mediated survival and activation of human eosinophils, and it is able to replace inhaled glucocorticoids for the treatment of asthma; however, lidocaine has many side effects, including anesthesia. Therefore, a collection of commercial and novel, synthesized lidocaine analogues were investigated for inhibitory activity of the IL-5-stimulated proliferation of TF-1 cells, a CD34+, cytokine-dependent, erythroleukemic cell line model for eosinophil growth. Among 74 investigated compounds, 10 were more potent inhibitors of cell proliferation than lidocaine (average IC50 = 223 µM), with IC50 values ranging within 1-119 µM. This cell-based assay is an effective method for screening chemical compounds and has revealed promising lead compounds for the treatment of asthma.

A combinatorial library composed of eleven hydrazides A-K and eleven indolin-1,2-dione derivatives 1-11 has been designed to formally generate sublibraries of 22 mixtures, M1-M22 comprising of 121 Schiff bases, A-K(1-11). The designed library has been synthesized by the solution-phase method and microwave-assisted synthetic techniques. The formation of individual compounds of each mixture was confirmed by Direct Analysis in Real Time (DART) as ionization technique connected to an Ion Trap as a mass detector. The synthesized mixtures were evaluated for their antimycobacterial activity against four Mycobacterium strains; M. intercellulari, M. xenopi, M. cheleneoi and M. smegmatis. Variable antimycobacterial activity was revealed with the investigated mixtures and maximum activity was shown by M8, M10, M11, and M15 with MIC values of 1.5, 3.1, 6.2 and 0.09 μg/mL, respectively. Application of the indexed method of analysis on these active mixtures revealed that compounds D8, D10 and D11 may contribute to the activity of the tested mixtures.

A facile and efficient method for synthesis of fenamic acid hydrazides from their acids in one-step reaction under microwave irradiation and solvent-free conditions was developed. Compared with the two-step conventional heating method, the process was simple, the reaction time was very short and the yields were almost quantitative.

In the title compound, C17H16N6O2S, an intramolecular N—H…O interaction generates an S(6) ring. The pyridine ring makes a dihedral angle of 71.38 (11)° with the thiophene ring. In the crystal, molecules are linked by a pair of N—H…N hydrogen bonds, forming an inversion dimer. The dimers are stacked in columns along the b axis through weak intermolecular C—H…N hydrogen bonds.

A novel series of Schiff bases 5b-g was synthesized by the reaction of N-substitutedbenzylisatin 3b-g with nalidixic acid hydrazide 4 in order to optimize the antimycobacterial activity of our lead Schiff base 5a. Antimycobacterial (anti-mtb) activity of the synthesized hydrazones was investigated against four Mycobacterium strains: M. intercellulari, M. xenopi, M. cheleneo and M. smegmatis. It was found that para-substitution, with electron withdrawing group, of benzyl moiety in N-benzylisatins resulted in 7 fold enhancement of the anti-mtb activity as shown with compounds 5b, 5d and 5f (MIC 0.09 μg/ml) with p-chloro, fluoro and nitro substituents respectively. In silico docking study of these hydrazones with mtb-DNA gyrase revealed that there is parallelism between the antimycobacterial activity of these hydrazones and docking with the active site of the mtb-DNA gyrase B subunit.

A novel series of Schiff bases 5b-g was synthesized by the reaction of N-substitutedbenzylisatin 3b-g with nalidixic acid hydrazide 4 in order to optimize the antimycobacterial activity of our lead Schiff base 5a. Antimycobacterial (anti-mtb) activity of the synthesized hydrazones was investigated against four Mycobacterium strains: M. intercellulari, M. xenopi, M. cheleneo and M. smegmatis. It was found that para-substitution, with electron withdrawing group, of benzyl moiety in N-benzylisatins resulted in 7 fold enhancement of the anti-mtb activity as shown with compounds 5b, 5d and 5f (MIC 0.09 μg/ml) with p-chloro, fluoro and nitro substituents respectively. In silico docking study of these hydrazones with mtb-DNA gyrase revealed that there is parallelism between the antimycobacterial activity of these hydrazones and docking with the active site of the mtb-DNA gyrase B subunit.

BACKGROUND: Cancer is one of the most dreaded diseases and it is a leading cause of mankind death worldwide. Recent reports documented a remarkable antiproliferative activity of isatin nucleus against various cancer cell lines. The current work describes the antiproliferative activity of Schiff bases of combinatorial mixtures of the isatin derivatives M1-M22 as well as the individual compounds 1-11(A-K) of these combinatorial mixtures. RESULTS: The designed combinatorial library composed from eleven hydrazides A-K and eleven isatin derivatives 1-11 has been synthesized to formally generate 22 mixtures, M1-M22 of 121 Schiff bases, and their antiproliferative activity against K562 chronic myelogenous leukemia cells was evaluated. The indexed method of analysis of the prepared library was applied to elucidate the active components in the tested mixtures M1-M22. The predictions from the crossing procedure was validated through evaluation of the antiproliferative activity of individual compounds 1-11(A-K) of the library. Individual compounds 1-11(A-K) were also evaluated against the non-tumorigenic MCF-12A cell line to investigate their selectivity. A pharmacophore model was developed to further optimize the antiproliferative activity among this series of compounds. CONCLUSIONS: Variable antiproliferative activity was revealed with the investigated mixtures M1-M22 and the individual compounds 1-11(A-K). Most of the tested mixtures and several individual Schiff bases displayed high potency with IC50 values in the low micromolar range. A considerable selectivity of some individual compounds to the tumorigenic K562 cell line compared with the non-tumorigenic MCF-12A cell line was observed as indicated by their selectivity index (SI).

BACKGROUND: Cancer is one of the most dreaded diseases and it is a leading cause of mankind death worldwide. Recent reports documented a remarkable antiproliferative activity of isatin nucleus against various cancer cell lines. The current work describes the antiproliferative activity of Schiff bases of combinatorial mixtures of the isatin derivatives M1-M22 as well as the individual compounds 1-11(A-K) of these combinatorial mixtures. RESULTS: The designed combinatorial library composed from eleven hydrazides A-K and eleven isatin derivatives 1-11 has been synthesized to formally generate 22 mixtures, M1-M22 of 121 Schiff bases, and their antiproliferative activity against K562 chronic myelogenous leukemia cells was evaluated. The indexed method of analysis of the prepared library was applied to elucidate the active components in the tested mixtures M1-M22. The predictions from the crossing procedure was validated through evaluation of the antiproliferative activity of individual compounds 1-11(A-K) of the library. Individual compounds 1-11(A-K) were also evaluated against the non-tumorigenic MCF-12A cell line to investigate their selectivity. A pharmacophore model was developed to further optimize the antiproliferative activity among this series of compounds. CONCLUSIONS: Variable antiproliferative activity was revealed with the investigated mixtures M1-M22 and the individual compounds 1-11(A-K). Most of the tested mixtures and several individual Schiff bases displayed high potency with IC50 values in the low micromolar range. A considerable selectivity of some individual compounds to the tumorigenic K562 cell line compared with the non-tumorigenic MCF-12A cell line was observed as indicated by their selectivity index (SI).

Double hydrophilic block copolymers (DHBC) were prepared by end-to-end coupling of two biocompatible water-soluble homopolymers: the polysaccharide dextran (Mw 8300 or 14,700 g mol1) and -amino poly(ethylene glycol) (PEG-NH2, Mw 3000 or 7000 g mol1). The synthesis involved, first, specific oxidation of the dextran terminal aldehyde group and, second, covalent linkage of PEG-NH2 via a lactone aminolysis reaction. The diblock copolymers dextran-PEG (DEX-PEG) were converted in high yield into the corresponding carboxymethyldextran-PEG (CMD-PEG) derivatives with control over the degree of substitution, from 30 to 85 mol% CH2COOH groups per glucopyranosyl unit. Further modifications of a CMD-PEG block copolymer led to N-(2-aminoethyl)carbamidomethyldextran-PEG yielding a pair of oppositely-charged DHBC of identical charge density, chain length, and neutral block/charged block content. The properties of CMD-PEG in aqueous solutions were studied by static and dynamic light scattering as a function of solution pH, providing evidence of the pH-sensitive assembly of the copolymers driven by inter- and intra-chain hydrogen-bond formation.